HopeStage
Back to all studies
CompletedNCT01043250

Appetite and eating behavior during antipsychotic treatment for schizophrenia

About this titleRead the official source — NCT01043250
Observational studyAges 19–59South Korea
The study in practice

Understand this study

Who was this study for?

Listed age limits: 19 years to 59 years.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateMay 2009
Recruitment status
Completed
Enrollment listed in the registry
81
Sponsor
Samsung Medical Center
Sponsor type
Hospital / academic medical center
Study type
Observational
Intervention type
Interview / survey / observational
Locations
South Korea
Age range
From 19 Years to 59 Years
Official registry ID
NCT01043250
Official title
Show the full official title

Effects of Atypical Antipsychotics on Appetite and Eating Behavior of Schizophrenia Patients: Analysis for Three Drugs, Olanzapine, Risperidone, and Aripiprazole, Known to Induce Different Degrees of Weight Gain

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Seoul

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Samsung Medical Center, a hospital or academic medical center.

Who was this study for?

Listed age limits: 19 years to 59 years.

Want to explore more studies?

Explore studies